AVIR Stock-Based Compensation
Atea Pharmaceuticals Inc · Stock-Based Compensation
AVIR Stock-Based Compensation
Latest reported$3.38Mperiod ending
AVIR Quarterly Stock-Based Comp ($146.00K → $3.38M)
Quarterly stock-based compensation
High-resolution chart · PNG
AVIR stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 3,381,000 | |
| 3,729,000 | |
| 4,585,000 | |
| 4,517,000 | |
| 4,667,000 | |
| 6,951,000 | |
| 14,297,000 | |
| 12,164,000 | |
| 12,720,000 | |
| 12,586,000 | |
| 12,157,000 | |
| 12,383,000 | |
| 12,353,000 | |
| 12,535,000 | |
| 11,645,000 | |
| 11,504,000 | |
| 11,908,000 | |
| 11,661,000 | |
| 11,351,000 | |
| 10,990,000 | |
| 10,007,000 | |
| 7,273,000 | |
| 2,821,000 | |
| 4,238,000 | |
| 209,000 | |
| 189,000 | |
| 174,000 | |
| 157,000 | |
| 147,000 | |
| 146,000 |